Exciting News! Saama Wins “AI-based Life Sciences Solution of the Year” Award in 2026 AI Breakthrough Awards
For 60 years, clinical trial data has moved on a one-way delay: sites collect it, sponsors analyze it, and only then does it reach the
There’s a quiet assumption baked into most “AI for clinical programming” pitches: that the hard part is generating code. Well, it isn’t. Any model can
Clinical development has always been expensive. But in 2026, the economics are drawing sharper attention. Developing a single new molecular entity now routinely requires between
Modern clinical trials generate data continuously, from the moment the first patient is enrolled. Yet most data management teams are still built around workflows designed
The drug development industry is moving faster than ever, and timelines are continuing to shorten across parts of the process. AI is increasingly being applied
Ask any clinical operations leader where study startup time disappears, and the answer rarely points to a single dramatic failure. More often, the culprit is
Clinical trials generate enormous amounts of data. For decades, the industry has relied on a familiar approach to keep that data clean through rules, edit
The period immediately following Data Base Lock (DBL) is often the most stressful window in a clinical trial. While the “hard work” of data collection
In the high-stakes environment of clinical development, the burden of documentation has reached a tipping point. Medical writers and clinical teams are increasingly sidelined by
Get our perspectives on AL/ML in the life sciences industry directly to your inbox.
